Short time treatment with DEBIO‐0932 showed modest but statistically significant reduction of brain metastases as measured by BLI (Appendix Fig S2A), allowing us to assess early changes after HSP90 inhibition in cancer cells. This evidence concerns the gene HSP90AA1 and cancer.